Namperumalsamy, Aravind Eye Hospital chairman, passes away in Madurai
Born in July 9, 1940, in a small hamlet with an agricultural background in Theni district, he did his MBBS from Madurai Medical College and moved to Boston, USA, to pursue higher education. He was the first retina specialist in the country. He practised in the Erskine Hospital Madurai, (now known as Government Rajaji Hospital) before starting his own venture, his elder son N. Venkatesh Prajna, said.
Dr. Namperumalsamy received the Padma Shri in 2007 for his immense contributions in the field of Ophthalmology. He received several awards through the course of an illustrious, and long career.
The cremation is expected to be performed at Ambasamudram in Theni district on Friday (July 25). He leaves behind his wife Nachiar and two sons - Venkatesh Prajna and Vishnu Prasad.
Condolences
Amar Agarwal, chairman, Dr. Agarwals Group of Eye Hospitals said Dr. Namperumalsamy was a doyen in Ophthalmology. 'What the Aravind eye care group has created under his leadership is just phenomenal. His contribution is not only in the number of patients he treated, which was huge, but also the number of doctors he trained. All these doctors are treating patients all over the world and helping eradicate blindness. The legacy he has left being will remain forever.'
Mohan Rajan, chairman and medical director, Rajan Eye Care Hospital, said, 'Dr NAM is no more, but his legacy lives on. Very rarely do we see a combination of a great teacher, great clinician, fantastic surgeon, great researcher, good speaker and an able administrator in one person, he was all of this,' he said.
Dr NAM, along with Dr Badrinath, was one of the earliest movers as far as the vitreoretinal surgery was concerned in this part of the world. 'He is a great inspiration, a role model and a motivation for all the ophthalmologists in the country and across the world. He has literally put India in a prominent position in the world map of Ophthalmology,' he added.
C. Ramasubramanian, psychiatrist and founder M.S. Chellamuthu Trust & Research Foundation said Dr NAM was concerned for the differently-abled population. He was instrumental in popularising the 'Arvind model' which tried to take ophthalmological care to all people irrespective of passing capacity. Dr. NAM had also advocated for community psychiatry, in order to make it more accessible, Dr CRS said and recalled an event where the late President APJ Abdul Kalam was amazed during his visit to Aravind Eye Hospital over the seamless doctor-patient care rendered on a mass scale.
Hari Thiagarajan, managing director, Thiagarajar Mills said Dr NAM was Madurai's pride. 'He was an alumni of Thiagarajar College and a well wisher of the institution. He continued the visionary path set by the founder of Aravind Eye Care and provided the group with moral and outstanding leadership. Under his tutelage, Aravind expanded and grew in great measure. 'He was a gentle person and care for the betterment of society especially, the rural India,' Mr. Thiagarajan added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
6 hours ago
- Time of India
Firm running urban PHCs in Doon fined Rs 5L for healthcare lapses
Dehradun: A private company operating primary health centres (PHCs) in Dehradun in a public-private partnership (PPP) mode was fined Rs 5 lakh, following inspections across 12 urban PHCs by officials of the district administration on Wednesday. Tired of too many ads? go ad free now A recommendation has been made to the chief secretary to terminate their contract. The inspections following several complaints, revealed missing doctors at many centres and ghost entries for junior doctors, nurses, and health personnel. Officials said medicines were expired, and there were lapses in cleanliness and sanitation. Officials also found breaks in cold chain maintenance of vaccines and medicines, no drinking water, no sitting space for patients and attendants, damaged equipment, and unclean washrooms, among several other violations. At some centres, even patients' registers were not being maintained. Chief development officer, Abhinav Shah, told TOI, "The Rajasthan-based company, Akshansh and Chitransh JV Private Ltd, was fined for several lapses in health care." Officials said that the original MoU of the company is being reviewed, and more penalties will be levied if violations are found.
Time of India
10 hours ago
- Time of India
Scalpel meets software: Robotic surgeries go high-tech in A'bad
Times News Network R obots are reshaping the future of surgeries in Ahmedabad. Case in point: a joint replacement surgery on July 26 at a city hospital where a next-gen fully autonomous robot was used for a joint replacement procedure. It was the clinical trial for a US-based robotics company specializing in joint replacement surgeries. The saw-based robotic arm with seven-axis movement imitated the human hand movements to perform the successful procedure. Dr Vikram Shah, CMD of Shalby Hospitals, who was part of the trial, said that it was a new chapter in use of robotics for surgeries with a fully-automatic system. The hospital currently performs about 20% of its total surgeries with robots. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad Robotic surgery is gaining momentum across disciplines and hospitals in Ahmedabad, driven by patient preference for quicker recovery, reduced blood loss, and fewer complications. According to Dr Bharat Gadhvi, president of the Ahmedabad Hospitals and Nursing Homes Association (AHNA) and regional director at HCG Hospitals, about 15–20% of surgeries in major hospitals are now robot-assisted. "Patients today are looking for better results with relatively less recovery time and less blood requirements. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Thus, almost all major hospitals have got robots for surgical procedures." Dr Parth Desai, COO of KD Hospital, said they are seeing a rise in robot-assisted surgeries in disciplines like oncology, orthopaedics, gastrointestinal, and bariatrics. "In the past few years, we have seen an increase in both facilities with robots and trained human resources in the procedure that has made the transition possible," he said. On the flip side, experts pointed out the relatively high cost when compared to conventional surgery and the non-inclusion of such procedures in several health insurance plans. They added that the expertise is still concentrated in Tier 1 cities, and the cost of installation is often prohibitive for small- and mid-sized hospitals. "From a surgeon's point of view, the entire system provides much more precision. Imagine looking at the area to be operated on 10 times bigger and in a 3D view. Thus, while it has remained a go-to choice for cancer surgeries, now many benign tumours are also being removed through robotic procedures," said Dr Mahesh Patel, GI onco-surgeon at Zydus Hospital.
Hindustan Times
11 hours ago
- Hindustan Times
Who is Susan Monarez? Sentae confirms new CDC director for Trump administration
The Senate on Tuesday confirmed Susan Monarez to be President Donald Trump's director of the U.S. Centers for Disease Control and Prevention. FILE - Susan Monarez, President Donald Trump's nominee to be director of the Centers for Disease Control and Prevention, arrives to testify before the Senate HELP Committee, at the Capitol in Washington, Wednesday, June 25, 2025. (AP Photo/J. Scott Applewhite, file)(AP) Monarez, 50, was named acting director in January and then tapped as the nominee in March after Trump abruptly withdrew his first choice, David Weldon. The Atlanta-based federal agency, tasked with tracking diseases and responding to health threats, has been hit by widespread staff cuts, key resignations and heated controversy over long-standing CDC vaccine policies upended by Health Secretary Robert F. Kennedy Jr. At her confirmation hearing, Monarez said she values vaccines and rigorous scientific evidence, but she largely dodged questions about her dealings with Kennedy, an antivaccine activist who has sought to dismantle some of the agency's previous protocols and decisions. With the 51-47 vote in favor of Monarez, she becomes the first CDC director to pass through Senate confirmation under a 2023 law. She holds a doctorate in microbiology and immunology from the University of Wisconsin, and did postdoctoral research at Stanford University. Prior to the CDC, Monarez was largely known for her government roles in health technology and biosecurity.
